5:27 PM
 | 
Feb 26, 2007
 |  BC Extra  |  Company News

Novartis gets Galvus approvable letter

Novartis (NVS; SWX:NOVN) received an approvable letter from FDA for Galvus...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >